Relationship between lymphocyte count, serum zinc and copper during zinc acetate administration in hemodialysis patients with hypozinemia .
Not Applicable
- Conditions
- ymphopenia in hemodialysis patients
- Registration Number
- JPRN-UMIN000036716
- Lead Sponsor
- Fujita Memorial Hospital
- Brief Summary
Examination end
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not get consent for the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increased number of lymphocytes after 12 months by zinc acetate administration
- Secondary Outcome Measures
Name Time Method To evaluate the safety of zinc acetate administration from clinical adverse events and serum zinc and copper levels